Cite
HARVARD Citation
Pico de Coaña, Y. et al. (n.d.). Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients. Journal for immunotherapy of cancer. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pico de Coaña, Y. et al. (n.d.). Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients. Journal for immunotherapy of cancer. p. . [Online].